The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUl56 and pUl89

Journal of Virology

Volumn 87, Issue 3, 2013, Pages 1720-1732

  Borst, Eva Maria ^a   Kleine Albers, Jennifer ^a   Gabaev, Ildar ^a   Babic, Marina ^d   Wagner, Karen ^a   Binz, Anne ^a   Degenhardt, Inga ^b,c   Kalesse, Markus ^b,c   Jonjić, Stipan ^d   Bauerfeind, Rudolf ^a   Messerle, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; LIGAND; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; VIRUS PROTEIN PUL51; VIRUS PROTEIN PUL56; VIRUS PROTEIN PUL89;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL NUCLEUS; COMPLEX FORMATION; CYTOMEGALOVIRUS INFECTION; DNA CLEAVAGE; DNA PACKAGING; DNA REPLICATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; NUCLEAR REPLICATION COMPARTMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; PROTEIN TARGETING; REGULATORY MECHANISM; VIRUS GENOME; VIRUS MUTANT; VIRUS REPLICATION;

CELLS, CULTURED; CYTOMEGALOVIRUS; DNA, VIRAL; ENDODEOXYRIBONUCLEASES; HUMANS; HYDROLYSIS; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRUS ASSEMBLY;

EID: 84873054290     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01955-12     Document Type: Article

References (78)

1. Mocarski ES, Shenk T, Pass RF. 2007. Cytomegaloviruses, p 2702-2772. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Cannon MJ, Schmid DS, Hyde TB. 2010. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 20:202-213.
3. Ljungman P, Hakki M, Boeckh M. 2010. Cytomegalovirus in hematopoietic stem cell transplant recipients. Infect. Dis. Clin. North Am. 24: 319-337.
4. Kotton CN. 2010. Management of cytomegalovirus infection in solid organ transplantation. Nat. Rev. Nephrol. 6:711-721.
5. Fisher RA. 2009. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation. Transpl. Infect. Dis. 11:195-202.
6. Hyde TB, Schmid DS, Cannon MJ. 2010. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev. Med. Virol. 20:311-326.
7. Nigro G, Adler SP. 2011. Cytomegalovirus infections during pregnancy. Curr. Opin. Obstet. Gynecol. 23:123-128.
8. Emery VC, Hassan-Walker AF. 2002. Focus on new drugs in development against human cytomegalovirus. Drugs 62:1853-1858.
9. Yang K, Wills EG, Baines JD. 2011. A mutation in UL15 of herpes simplex virus 1 that reduces packaging of cleaved genomes. J. Virol. 85: 11972-11980.
10. Andrei G, De Clercq E, Snoeck R. 2009. Drug targets in cytomegalovirus infection. Infect. Disord. Drug Targets 9:201-222.
11. Bogner E. 2002. Human cytomegalovirus terminase as a target for antiviral chemotherapy. Rev. Med. Virol. 12:115-127.
12. Price NB, Prichard MN. 2011. Progress in the development of new therapies for herpesvirus infections. Curr. Opin. Virol. 1:548-554.
13. Reefschlaeger J, Bender W, Hallenberger S, Weber O, Eckenberg P, Goldmann S, Haerter M, Buerger I, Trappe J, Herrington JA, Haebich D, Ruebsamen-Waigmann H. 2001. Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action. J. Antimicrob. Chemother. 48:757-767.
14. Hwang JS, Kregler O, Schilf R, Bannert N, Drach JC, Townsend LB, Bogner E. 2007. Identification of acetylated, tetrahalogenated benzimidazole D-ribonucleosides with enhanced activity against human cytomegalovirus. J. Virol. 81:11604-11611.
15. Underwood MR, Harvey RJ, Stanat SC, Hemphill ML, Miller T, Drach JC, Townsend LB, Biron KK. 1998. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 72:717-725.
16. McVoy MA, Nixon DE. 2005. Impact of 2-bromo-5,6-dichloro-1-beta- D-ribofuranosyl benzimidazole riboside and inhibitors of DNA, RNA, and protein synthesis on human cytomegalovirus genome maturation. J. Virol. 79:11115-11127.
17. Lischka P, Hewlett G, Wunberg T, Baumeister J, Paulsen D, Goldner T, Ruebsamen-Schaeff H, Zimmermann H. 2010. In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrob. Agents Chemother. 54:1290-1297.
18. Goldner T, Hewlett G, Ettischer N, Ruebsamen-Schaeff H, Zimmermann H, Lischka P. 2011. The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. J. Virol. 85:10884-10893.
19. Casjens SR. 2011. The DNA-packaging nanomotor of tailed bacteriophages. Nat. Rev. Microbiol. 9:647-657.
20. Rao VB, Feiss M. 2008. The bacteriophage DNA packaging motor. Annu. Rev. Genet. 42:647-681.
21. Sanchez V, Greis KD, Sztul E, Britt WJ. 2000. Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J. Virol. 74:975-986.
22. Gibson W. 2008. Structure and formation of the cytomegalovirus virion. Curr. Top. Microbiol. Immunol. 325:187-204.
23. Tandon R, Mocarski ES. 2012. Viral and host control of cytomegalovirus maturation. Trends Microbiol. 20:392-401.
24. Bogner E, Radsak K, Stinski MF. 1998. The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has specific nuclease activity. J. Virol. 72:2259-2264.
25. Scholz B, Rechter S, Drach JC, Townsend LB, Bogner E. 2003. Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. Nucleic Acids Res. 31:1426-1433.
26. Dittmer A, Drach JC, Townsend LB, Fischer A, Bogner E. 2005. Interaction of the putative human cytomegalovirus portal protein pUL104 with the large terminase subunit pUL56 and its inhibition by benzimidazole- D-ribonucleosides. J. Virol. 79:14660-14667.
27. Dittmer A, Bogner E. 2005. Analysis of the quaternary structure of the putative HCMV portal protein pUL104. Biochemistry 44:759-765.
28. Komazin G, Townsend LB, Drach JC. 2004. Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides. J. Virol. 78:710-715.
29. Hwang JS, Bogner E. 2002. ATPase activity of the terminase subunit pUL56 of human cytomegalovirus. J. Biol. Chem. 277:6943-6948.
30. Thoma C, Borst E, Messerle M, Rieger M, Hwang JS, Bogner E. 2006. Identification of the interaction domain of the small terminase subunit pUL89 with the large subunit pUL56 of human cytomegalovirus. Biochemistry 45:8855-8863.
31. Scheffczik H, Savva CG, Holzenburg A, Kolesnikova L, Bogner E. 2002. The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. Nucleic Acids Res. 30:1695-1703.
32. Nadal M, Mas PJ, Blanco AG, Arnan C, Sola M, Hart DJ, Coll M. 2010. Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain. Proc. Natl. Acad. Sci. U. S. A. 107:16078-16083.
33. Krosky PM, Underwood MR, Turk SR, Feng KW, Jain RK, Ptak RG, Westerman AC, Biron KK, Townsend LB, Drach JC. 1998. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol. 72:4721-4728.
34. Buerger I, Reefschlaeger J, Bender W, Eckenberg P, Popp A, Weber O, Graeper S, Klenk HD, Ruebsamen-Waigmann H, Hallenberger S. 2001. Anovel nonnucleoside inhibitor specifically targets cytomegalovirusDNA maturation via the UL89 and UL56 gene products. J. Virol. 75:9077-9086.
35. Champier G, Couvreux A, Hantz S, Rametti A, Mazeron MC, Bouaziz S, Denis F, Alain S. 2008. Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. Antivir. Ther. 13:643-654.
36. Thoma C, Bogner E. 2010. Short hairpin RNAs specific to human cytomegalovirus terminase subunit pUL89 prevent viral maturation. Antivir. Ther. 15:391-400.
37. Meissner CS, Köppen-Rung P, Dittmer A, Lapp S, Bogner E. 2011. A "coiled-coil" motif is important for oligomerization and DNA binding properties of human cytomegalovirus protein UL77. PLoS One 6:e25115. doi:10.1371/journal.pone.0025115.
38. Klupp BG, Granzow H, Keil GM, Mettenleiter TC. 2006. The capsidassociated UL25 protein of the alphaherpesvirus pseudorabies virus is nonessential for cleavage and encapsidation of genomic DNA but is required for nuclear egress of capsids. J. Virol. 80:6235-6246.
39. Cockrell SK, Sanchez ME, Erazo A, Homa FL. 2009. Role of the UL25 protein in herpes simplex virus DNA encapsidation. J. Virol. 83:47-57.
40. Pasdeloup D, Blondel D, Isidro AL, Rixon FJ. 2009. Herpesvirus capsid association with the nuclear pore complex and viral DNA release involve the nucleoporin CAN/Nup214 and the capsid protein pUL25. J. Virol. 83:6610-6623.
41. O'Hara M, Rixon FJ, Stow ND, Murray J, Murphy M, Preston VG. 2010. Mutational analysis of the herpes simplex virus type 1 UL25 DNA packaging protein reveals regions that are important after the viral DNA has been packaged. J. Virol. 84:4252-4263.
42. Rode K, Döhner K, Binz A, Glass M, Strive T, Bauerfeind R, Sodeik B. 2011. Uncoupling uncoating of herpes simplex virus genomes from their nuclear import and gene expression. J. Virol. 85:4271-4283.
43. Borst EM, Wagner K, Binz A, Sodeik B, Messerle M. 2008. The essential human cytomegalovirus gene UL52 is required for cleavage-packaging of the viral genome. J. Virol. 82:2065-2078.
44. Uetz P, Dong YA, Zeretzke C, Atzler C, Baiker A, Berger B, Rajagopala SV, Roupelieva M, Rose D, Fossum E, Haas J. 2006. Herpesviral protein networks and their interaction with the human proteome. Science 311: 239-242.
45. Fossum E, Friedel CC, Rajagopala SV, Titz B, Baiker A, Schmidt T, Kraus T, Stellberger T, Rutenberg C, Suthram S, Bandyopadhyay S, Rose D, von Brunn A, Uhlmann M, Zeretzke C, Dong YA, Boulet H, Koegl M, Bailer SM, Koszinowski U, Ideker T, Uetz P, Zimmer R, Haas J. 2009. Evolutionarily conserved herpesviral protein interaction networks. PLoS Pathog. 5:e1000570. doi:10.1371/journal.ppat.1000570.
46. Vizoso Pinto MG, Pothineni VR, Haase R, Woidy M, Lotz-Havla AS, Gersting SW, Muntau AC, Haas J, Sommer M, Arvin AM, Baiker A. 2011. Varicella zoster virus ORF25 gene product: an essential hub protein linking encapsidation proteins and the nuclear egress complex. J. Proteome. Res. 10:5374-5382.
47. Glass M, Busche A, Wagner K, Messerle M, Borst EM. 2009. Conditional and reversible disruption of essential herpesvirus proteins. Nat. Methods 6:577-579.
48. Borst EM, Hahn G, Koszinowski UH, Messerle M. 1999. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73:8320-8329.
49. Borst EM, Messerle M. 2005. Analysis of human cytomegalovirus oriLyt sequence requirements in the context of the viral genome. J. Virol. 79: 3615-3626.
50. Borst EM, Benkartek C, Messerle M. 2007. Use of bacterial artificial chromosomes in generating targeted mutations in human and mouse cytomegaloviruses, p 10.32.1-10.32.30. In Coligan JE, Bierer B, Margulies DH, Shevach EM, Strober W, Coico R (ed), Current protocols in immunology. John Wiley & Sons, New York, NY.
51. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerlessDNA manipulation in Escherichia coli. Biotechniques 40:191-197.
52. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
53. Gloeckner CJ, Boldt K, Schumacher A, Roepman R, Ueffing M. 2007. A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7:4228-4234.
54. Gloeckner CJ, Boldt K, Ueffing M. 2009. Strep/FLAG tandem affinity purification (SF-TAP) to study protein interactions. Curr. Protoc. Protein Sci. Chapter 19:19.20.1-19.20.19.
55. Baker A, Cotten M. 1997. Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier. Nucleic Acids Res. 25:1950-1956.
56. Banaszynski LA, Chen LC, Maynard-Smith LA, Ooi AG, Wandless TJ. 2006. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126:995-1004.
57. Penfold ME, Mocarski ES. 1997. Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology 239:46-61.
58. Giesen K, Radsak K, Bogner E. 2000. Targeting of the gene product encoded by ORF UL56 of human cytomegalovirus into viral replication centers. FEBS Lett. 471:215-218.
59. al-Kobaisi MF, Rixon FJ, McDougall I, Preston VG. 1991. The herpes simplex virus UL33 gene product is required for the assembly of full capsids. Virology 180:380-388.
60. Reynolds AE, Fan Y, Baines JD. 2000. Characterization of the U(L)33 gene product of herpes simplex virus 1. Virology 266:310-318.
61. Beard PM, Taus NS, Baines JD. 2002. DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells. J. Virol. 76:4785-4791.
62. Yang K, Baines JD. 2006. The putative terminase subunit of herpes simplex virus 1 encoded by UL28 is necessary and sufficient to mediate interaction between pUL15 and pUL33. J. Virol. 80:5733-5739.
63. Yang K, Poon AP, Roizman B, Baines JD. 2008. Temperature-sensitive mutations in the putative herpes simplex virus type 1 terminase subunits pUL15 and pUL33 preclude viral DNA cleavage/packaging and interaction with pUL28 at the nonpermissive temperature. J. Virol. 82:487-494.
64. Beilstein F, Higgs MR, Stow ND. 2009. Mutational analysis of the herpes simplex virus type 1 DNA packaging protein UL33. J. Virol. 83:8938-8945.
65. Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, Liu F. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228.
66. Yu D, Silva MC, Shenk T. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U. S. A. 100:12396-12401.
67. To A, Bai Y, Shen A, Gong H, Umamoto S, Lu S, Liu F. 2011. Yeast two hybrid analyses reveal novel binary interactions between human cytomegalovirus- encoded virion proteins. PLoS One 6:e17796. doi:10.1371 /journal.pone.0017796.
68. Lee S, Salwinski L, Zhang C, Chu D, Sampankanpanich C, Reyes NA, Vangeloff A, Xing F, Li X, Wu TT, Sahasrabudhe S, Deng H, Lacount DJ, Sun R. 2011. An integrated approach to elucidate the intra-viral and viral-cellular protein interaction networks of a gamma-herpesvirus. PLoS Pathog. 7:e1002297. doi:10.1371/journal.ppat.1002297.
69. Yang K, Homa F, Baines JD. 2007. Putative terminase subunits of herpes simplex virus 1 form a complex in the cytoplasm and interact with portal protein in the nucleus. J. Virol. 81:6419-6433.
70. Giesen K, Radsak K, Bogner E. 2000. The potential terminase subunit of human cytomegalovirus, pUL56, is translocated into the nucleus by its own nuclear localization signal and interacts with importin alpha. J. Gen. Virol. 81:2231-2244.
71. Beard PM, Baines JD. 2004. The DNA cleavage and packaging protein encoded by the UL33 gene of herpes simplex virus 1 associates with capsids. Virology 324:475-482.
72. Wills E, Scholtes L, Baines JD. 2006. Herpes simplex virus 1 DNA packaging proteins encoded by UL6, UL15, UL17, UL28, and UL33 are located on the external surface of the viral capsid. J. Virol. 80:10894-10899.
73. Leelawong M, Guo D, Smith GA. 2011. A physical link between the pseudorabies virus capsid and the nuclear egress complex. J. Virol. 85: 11675-11684.
74. Perng YC, Qian Z, Fehr AR, Xuan B, Yu D. 2011. The human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts. J. Virol. 85:4841-4852.
75. Qian Z, Leung-Pineda V, Xuan B, Piwnica-Worms H, Yu D. 2010. Human cytomegalovirus protein pUL117 targets the mini-chromosome maintenance complex and suppresses cellular DNA synthesis. PLoS Pathog. 6:e1000814. doi:10.1371/journal.ppat.1000814.
76. Tandon R, Mocarski ES. 2011. Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J. Virol. 85:7129-7141.
77. Ruzsics Z, Borst EM, Bosse JB, Brune W, Messerle M. 2013. Manipulating cytomegalovirus genomes by BAC mutagenesis: strategies and applications, p 37-57. In Reddehase MJ (ed), Cytomegaloviruses: from molecular pathogenesis to intervention, vol 1. Caister Academic Press, Hethersett, Norwich, United Kingdom.
78. Higgs MR, Preston VG, Stow ND. 2008. The UL15 protein of herpes simplex virus type 1 is necessary for the localization of the UL28 and UL33 proteins to viral DNA replication centres. J. Gen. Virol. 89:1709-1715.